ANORRIS

manufacturer's individual instructions ...always

manufacturer's individual instructions ...always

Has anyone come up with a way to comply with the "peer review" in AABB Standard 8.2 (Transfusing facilities shall have a peer-review program that monitors and addresses transfusion practices for all categories of blood and blood components.) other than presenting data at Transfusion Committee Meetings?

We also order only pooled cryo from our supplier, but our previous pooling procedure stated that a small amount of sterile saline should be added to each bag after adding it's contents to the pool bag to remove additional cryo.  At the facility where I trained, we did not do that.  I don't know if the additional recovery is worth it or not.

we purchase pooled cryo from the blood center.  no more pooling
 

manufacturer's individual instructions ...always

manufacturer's individual instructions ...always

We are debating the proper use of PPE in the lab so we are looking for anyone who has a pretty granular policy or procedure for this that they would be willing to share.  The debates are around things like whether you should wear gloves to touch a keyboard or phone that someone wearing gloves has been using.  Then it progressed to refrigerator door handles.  If anyone has strict policies like this, then how do you deal with units of blood and paperwork?  If you touch papers wearing gloves or let them sit on workbench surfaces, can they then go to a clean section of the lab?  If you touch a unit of blood while wearing gloves then you send it to a patient's room is that a problem?  No I don't want to try that CDC recommendation from a few years back when they wanted us to disinfect the blood bags at issue.  The FDA said that wouldn't fly so it went nowhere.  Or is a policy that allows us to touch blood units sufficient for the rest of the lab and we should just be sensible and not lick our fingers when touching items in the lab like keyboards and door handles and papers?  Are there any evidence-based studies on what approach is required for adequate worker safety?  I appreciate your collective wisdom.

There is an option to check 'reagent not available' for the antisera you don't stock.

CAP also has a separate survey RBCAT (Red Blood Cell Antigen Typing) its 2 shipments a year, 2 specimens per survey and each specimen has typing for multiple antigens

The provider who requests the Emergency release of the 2 units is who is asked to sign/take responsibility for the uncrossmatched blood, not the provider (usually surgeon or anesthesia) who gives the Transfuse order. However, we would make sure that the surgeon (or anesthesia) was aware that the unit being transfused was uncrossmatched - he/she could then determine whether or not they wanted to continue with the transfusion or wait for the crossmatch to be completed. We are a level III trauma center and this has not been an issue with TJC, CAP or the trauma surveyors from the state up to this point. You should probably check for regulations in your state, as a start.

I am enormously honoured to announce that I am going to be awarded the Gold Medal of the British Blood Transfusion Society at their Annual Scientific Meeting in Brighton this year.  It is awarded to an individual for their exceptional and long standing services to the Society and to the practice of blood transfusion in the UK.  Sorry if this sounds egocentric, but I am very excited.

I always considered antibody identification both art and science with a little magic thrown in for good measure.  

We would just give them the whole unit. Splitting the unit has labeling requirements - barcode labeling requirements - that are not practical for a 'once in a blue moon' situation.

Our stuff is stored for 10 years, with a set of notebooks for each year.  The patient's records are stored alphabetically within each year, with the current year's set is found in the Blood Bank.  We do not collate individual patient's records from year-to-year.   We do not search for expired patients in order to clean our printed records.  We just toss a year's worth when it is 10 years old.
Scott

Booooo, "Just Say No to FB!". 

We know that Malcolm - I was using the terminology that was existing at the time when Du was being used AND that we did not give RhIg to Du+ individuals then.  Besides, whoever heard of anti-Du (not me)?
Was it always Weak D in Great Britain?
Aside from the Pedantics, what is your take on RhIg for Weak D individuals?  I do not routinely perform Weak D testing on maternity patients.

AABB ---BOTH

But...but...but...
polyspecific reagent DOES contain anti-C3...
(And I do not think that Ms. Fabian would suggest ignoring any manufacturer's recommendations contrary to her quote above.)
 
Scott

I have heard from CAP on this question - and I quote:
" Mr. Saikin
If you are using polyspecific reagent, you are only required to confirm negative results with IgG-coated red cells.  C3-coated red cells are only required with anti-C3 reagents are used (sic).  The last sentence in the note for TRM.40210 states that if polyspecific reagent is used, the TRM.40200 applies.  I hope this helps.
Regards,
Sarah Fabian, MLS(ASCP)"
If you use polyahg, you only need to run IgG check cells to confirm negatives.

I have never seen that interp for polyahg requiring IgG and C3 sensitized cells.  It seems to me that the final sentence of referring to TRM.40200 allows the use of the IgG sensitized cells to document the reactivity of your poly reagent.  I know I am not the only one who interprets this.  I will f/u w CAP on this.

I scan them into a folder on my PC and throw away the paper copies

Do you all really believe that the unit paperwork is looked at during a massive transfusion event? Or is it checked afterwards?

lucky you if you know who the father of the baby is!!!!!  Minefield!!

We test the father of the baby. If he is Rh- Positive , we automatically give the mother RhoGam.